Wellington Management Group
NBIX icon

Wellington Management Group’s Neurocrine Biosciences NBIX Stock Holding History

Wellington Management Group’s Portfolio NBIX Stock Details NBIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$183M Sell
1,389,539
-355,021
-20% -$47.1M 0.03% 402
2025
Q4 		$247M Sell
1,744,560
-67,202
-4% -$9.74M 0.04% 335
2025
Q3 		$254M Sell
1,811,762
-217,096
-11% -$29.4M 0.04% 329
2025
Q2 		$255M Sell
2,028,858
-69,123
-3% -$7.93M 0.05% 310
2025
Q1 		$232M Buy
2,097,981
+640,556
+44% +$81.1M 0.04% 313
2024
Q4 		$199M Buy
1,457,425
+739,199
+103% +$91.4M 0.04% 371
2024
Q3 		$82.8M Sell
718,226
-181,267
-20% -$24.9M 0.01% 580
2024
Q2 		$124M Sell
899,493
-104,257
-10% -$14.3M 0.02% 493
2024
Q1 		$138M Sell
1,003,750
-195,792
-16% -$26.7M 0.02% 478
2023
Q4 		$158M Sell
1,199,542
-128,397
-10% -$14.8M 0.03% 440
2023
Q3 		$149M Sell
1,327,939
-71,500
-5% -$7.53M 0.03% 438
2023
Q2 		$132M Buy
1,399,439
+228,393
+20% +$22.3M 0.03% 486
2023
Q1 		$119M Sell
1,171,046
-35,007
-3% -$3.64M 0.02% 504
2022
Q4 		$144M Buy
1,206,053
+436,603
+57% +$51.1M 0.03% 450
2022
Q3 		$81.7M Buy
769,450
+325,301
+73% +$33M 0.02% 564
2022
Q2 		$43.3M Buy
444,149
+54,741
+14% +$5.05M 0.01% 720
2022
Q1 		$36.5M Buy
+389,408
New +$33M 0.01% 852
2021
Q4 		– Sell
-26,029
Closed -$2.5M – 2259
2021
Q3 		$2.5M Sell
26,029
-11,799
-31% -$1.11M ﹤0.01% 1651
2021
Q2 		$3.68M Sell
37,828
-281
-0.7% -$26.9K ﹤0.01% 1562
2021
Q1 		$3.71M Sell
38,109
-1,792
-4% -$188K ﹤0.01% 1488
2020
Q4 		$3.82M Buy
39,901
+15,683
+65% +$1.51M ﹤0.01% 1365
2020
Q3 		$2.33M Sell
24,218
-5,585
-19% -$646K ﹤0.01% 1389
2020
Q2 		$3.64M Sell
29,803
-12,549
-30% -$1.39M ﹤0.01% 1268
2020
Q1 		$3.67M Sell
42,352
-16,679
-28% -$1.63M ﹤0.01% 1255
2019
Q4 		$6.34M Sell
59,031
-655,156
-92% -$68.6M ﹤0.01% 1277
2019
Q3 		$64.4M Buy
714,187
+14,770
+2% +$1.38M 0.01% 659
2019
Q2 		$59.1M Buy
699,417
+631,711
+933% +$51.9M 0.01% 708
2019
Q1 		$5.96M Buy
67,706
+40,796
+152% +$3.41M ﹤0.01% 1342
2018
Q4 		$1.92M Sell
26,910
-1,078,462
-98% -$103M ﹤0.01% 1650
2018
Q3 		$136M Sell
1,105,372
-1,300,128
-54% -$148M 0.03% 488
2018
Q2 		$236M Buy
2,405,500
+33,827
+1% +$3.03M 0.05% 336
2018
Q1 		$197M Sell
2,371,673
-777,273
-25% -$65.6M 0.04% 383
2017
Q4 		$244M Sell
3,148,946
-546,163
-15% -$37.3M 0.05% 330
2017
Q3 		$226M Buy
3,695,109
+666,193
+22% +$35.2M 0.05% 321
2017
Q2 		$139M Buy
3,028,916
+621,540
+26% +$30.1M 0.03% 406
2017
Q1 		$104M Buy
2,407,376
+2,039,509
+554% +$87.4M 0.03% 493
2016
Q4 		$14.2M Buy
367,867
+21,329
+6% +$966K ﹤0.01% 1099
2016
Q3 		$17.5M Sell
346,538
-113,536
-25% -$5.65M ﹤0.01% 1022
2016
Q2 		$20.9M Buy
460,074
+39,902
+9% +$1.84M 0.01% 932
2016
Q1 		$16.6M Sell
420,172
-2,750
-0.7% -$109K ﹤0.01% 982
2015
Q4 		$23.9M Buy
422,922
+36,118
+9% +$1.84M 0.01% 904
2015
Q3 		$15.4M Sell
386,804
-185,694
-32% -$8.98M ﹤0.01% 1049
2015
Q2 		$27.3M Sell
572,498
-14,670
-2% -$622K 0.01% 907
2015
Q1 		$23.3M Sell
587,168
-231,750
-28% -$8.29M 0.01% 991
2014
Q4 		$18.3M Sell
818,918
-46,685
-5% -$885K ﹤0.01% 1073
2014
Q3 		$13.6M Buy
865,603
+14,440
+2% +$216K ﹤0.01% 1141
2014
Q2 		$12.6M Buy
851,163
+284,520
+50% +$4.02M ﹤0.01% 1187
2014
Q1 		$9.12M Sell
566,643
-117,560
-17% -$2.01M ﹤0.01% 1280
2013
Q4 		$6.39M Buy
684,203
+349,200
+104% +$3.41M ﹤0.01% 1387
2013
Q3 		$3.79M Sell
335,003
-95,400
-22% -$1.31M ﹤0.01% 1500
2013
Q2 		$5.76M Buy
+430,403
New +$5.29M ﹤0.01% 1386

Other funds holding NBIX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wellington Management Group's NBIX Position: Q1 2026 in Review

Wellington Management Group reduced its Neurocrine Biosciences (NBIX) stake by 20% in Q1 2026, selling an estimated $47.1M and leaving 1,389,539 shares worth $183M. The position accounts for 0.03% of the portfolio, ranked #402.

Wellington Management Group first reported a position in NBIX in Q2 2013 and has held it in 51 quarters since. The position peaked at $255M in Q2 2025. 694 funds tracked by Wall St. Rank hold NBIX as of Q1 2026.

  • Wellington Management Group held 1,389,539 shares of Neurocrine Biosciences worth $183M as of Q1 2026.
  • Wellington Management Group sold 355,021 Neurocrine Biosciences shares in Q1 2026, an estimated $47.1M.
  • Neurocrine Biosciences made up 0.03% of Wellington Management Group's portfolio in Q1 2026, its #402 holding.
  • Wellington Management Group first reported a position in Neurocrine Biosciences in Q2 2013 and has held it in 51 quarters since.
  • Wellington Management Group's Neurocrine Biosciences position peaked at $255M in Q2 2025.
  • 694 funds tracked by Wall St. Rank held Neurocrine Biosciences as of Q1 2026.

Based on Wellington Management Group's 13F filing for Q1 2026, filed 15 May 2026.